NCT05279365View on ClinicalTrials.gov

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2023

Conditions
SARS CoV 2 InfectionCOVID-19
Interventions
BIOLOGICAL

Pfizer/BioNTech (BNT162b2)

participants will receive a booster dose (1st booster or 2nd booster) of vaccine

BIOLOGICAL

Moderna

participants will receive a booster dose (1st booster or 2nd booster) of vaccine

Trial Locations (4)

78521

RECRUITING

Brownsville Independent School District, Brownsville

78539

RECRUITING

DHR Health Institute for Research and Development, Edinburg

78542

RECRUITING

Edinburg CISD School Based Health Center, Edinburg

78582

RECRUITING

Starr County Memorial Hospital, Rio Grande City

Sponsors
All Listed Sponsors
lead

DHR Health Institute for Research and Development

OTHER